Malignant hyperthermia
<p>Abstract</p> <p>Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine, and rarely...
Main Authors: | Pollock Neil, James Danielle, Davis Mark, Rosenberg Henry, Stowell Kathryn |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-04-01
|
Series: | Orphanet Journal of Rare Diseases |
Online Access: | http://www.OJRD.com/content/2/1/21 |
Similar Items
-
Prevalence of malignant hyperthermia diagnosis in obstetric patients in the United States, 2003 to 2014
by: Jean Guglielminotti, et al.
Published: (2020-01-01) -
Malignant hyperthermia
by: Oliver Bandschapp, et al.
Published: (2012-07-01) -
Malignant hyperthermia
by: Kirti N Saxena
Published: (2014-01-01) -
Malignant hyperthermia
by: Dong-Chan Kim
Published: (2012-11-01) -
Malignant hyperthermia
by: Michael P Phy
Published: (2016-01-01)